263 related articles for article (PubMed ID: 24441081)
1. Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes.
Haberger M; Bomans K; Diepold K; Hook M; Gassner J; Schlothauer T; Zwick A; Spick C; Kepert JF; Hienz B; Wiedmann M; Beck H; Metzger P; Mølhøj M; Knoblich C; Grauschopf U; Reusch D; Bulau P
MAbs; 2014; 6(2):327-39. PubMed ID: 24441081
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
[TBL] [Abstract][Full Text] [Related]
3. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of antibody oxidation by native mass spectrometry.
Haberger M; Heidenreich AK; Schlothauer T; Hook M; Gassner J; Bomans K; Yegres M; Zwick A; Zimmermann B; Wegele H; Bonnington L; Reusch D; Bulau P
MAbs; 2015; 7(5):891-900. PubMed ID: 26000623
[TBL] [Abstract][Full Text] [Related]
5. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential sites for tryptophan oxidation in recombinant antibodies using tert-butylhydroperoxide and quantitative LC-MS.
Hensel M; Steurer R; Fichtl J; Elger C; Wedekind F; Petzold A; Schlothauer T; Molhoj M; Reusch D; Bulau P
PLoS One; 2011 Mar; 6(3):e17708. PubMed ID: 21390239
[TBL] [Abstract][Full Text] [Related]
7. Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability.
Grunert I; Heinrich K; Ernst J; Hingar M; Briguet A; Leiss M; Wuhrer M; Reusch D; Bulau P
ACS Omega; 2022 Feb; 7(4):3671-3679. PubMed ID: 35128275
[TBL] [Abstract][Full Text] [Related]
8. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody.
Miller AK; Hambly DM; Kerwin BA; Treuheit MJ; Gadgil HS
J Pharm Sci; 2011 Jul; 100(7):2543-50. PubMed ID: 21287557
[TBL] [Abstract][Full Text] [Related]
9. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
Zhang Z; Yan Y; Wang S; Li N
MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
[TBL] [Abstract][Full Text] [Related]
10. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
[TBL] [Abstract][Full Text] [Related]
11. Multiattribute Monitoring of Antibody Charge Variants by Cation-Exchange Chromatography Coupled to Native Mass Spectrometry.
Haberger M; Heidenreich AK; Hook M; Fichtl J; Lang R; Cymer F; Adibzadeh M; Kuhne F; Wegele H; Reusch D; Bonnington L; Bulau P
J Am Soc Mass Spectrom; 2021 Aug; 32(8):2062-2071. PubMed ID: 33687195
[TBL] [Abstract][Full Text] [Related]
12. A chemical and computational approach to comprehensive glycation characterization on antibodies.
Saleem RA; Affholter BR; Deng S; Campbell PC; Matthies K; Eakin CM; Wallace A
MAbs; 2015; 7(4):719-31. PubMed ID: 26030340
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.
Gandhi S; Ren D; Xiao G; Bondarenko P; Sloey C; Ricci MS; Krishnan S
Pharm Res; 2012 Jan; 29(1):209-24. PubMed ID: 21845507
[TBL] [Abstract][Full Text] [Related]
14. Effect of Trastuzumab-HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab.
Spanov B; Aboagye V; Olaleye O; Govorukhina N; van de Merbel NC; Bischoff R
Front Chem; 2021; 9():794247. PubMed ID: 35047480
[TBL] [Abstract][Full Text] [Related]
15. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
[TBL] [Abstract][Full Text] [Related]
17. Early determination of potential critical quality attributes of therapeutic antibodies in developability studies through surface plasmon resonance-based relative binding activity assessment.
Wang S; Wang Y; Li Z; Hong Y; Wang Z; Fan J; Wang Q; Ge Y; Zhao X; Cheng G; Chen C; Wu Y; Fu Y
MAbs; 2024; 16(1):2374607. PubMed ID: 38956880
[TBL] [Abstract][Full Text] [Related]
18. Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry.
Yan B; Valliere-Douglass J; Brady L; Steen S; Han M; Pace D; Elliott S; Yates Z; Han Y; Balland A; Wang W; Pettit D
J Chromatogr A; 2007 Sep; 1164(1-2):153-61. PubMed ID: 17640657
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
20. Low pK
Xu X; O'Callaghan JA; Guarnero Z; Qiu H; Li N; Potocky T; Kamen DE; Graham KS; Shameem M; Yang TC
Biophys J; 2022 Mar; 121(6):1081-1093. PubMed ID: 35122736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
